PL330864A1 - Orally administered composition containing antimycotic compounds of triazole - Google Patents

Orally administered composition containing antimycotic compounds of triazole

Info

Publication number
PL330864A1
PL330864A1 PL97330864A PL33086497A PL330864A1 PL 330864 A1 PL330864 A1 PL 330864A1 PL 97330864 A PL97330864 A PL 97330864A PL 33086497 A PL33086497 A PL 33086497A PL 330864 A1 PL330864 A1 PL 330864A1
Authority
PL
Poland
Prior art keywords
triazole
composition containing
orally administered
administered composition
antimycotic compounds
Prior art date
Application number
PL97330864A
Other languages
English (en)
Inventor
Surendra A Sangekar
Winston A Vadino
Ping I Lee
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of PL330864A1 publication Critical patent/PL330864A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
PL97330864A 1996-06-28 1997-06-25 Orally administered composition containing antimycotic compounds of triazole PL330864A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US67243296A 1996-06-28 1996-06-28

Publications (1)

Publication Number Publication Date
PL330864A1 true PL330864A1 (en) 1999-06-07

Family

ID=24698529

Family Applications (1)

Application Number Title Priority Date Filing Date
PL97330864A PL330864A1 (en) 1996-06-28 1997-06-25 Orally administered composition containing antimycotic compounds of triazole

Country Status (16)

Country Link
EP (1) EP0914100A1 (2)
JP (1) JP2000514059A (2)
KR (1) KR20000022294A (2)
CN (1) CN1228693A (2)
AU (1) AU731704B2 (2)
BR (1) BR9710069A (2)
CA (1) CA2258683C (2)
CZ (1) CZ421498A3 (2)
HU (1) HUP9903869A3 (2)
IL (1) IL127780A0 (2)
NO (1) NO986087L (2)
NZ (1) NZ333514A (2)
PL (1) PL330864A1 (2)
SK (1) SK177598A3 (2)
TR (1) TR199802718T2 (2)
WO (1) WO1998000116A1 (2)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3608800B2 (ja) * 1997-03-26 2005-01-12 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 抗真菌剤およびポリマーでコートされたコアを有するペレット剤
JP2002517431A (ja) * 1998-06-11 2002-06-18 イーエム インダストリーズ インコーポレイテッド マイクロ浸透圧制御薬物送達システム
BR9906712A (pt) * 1998-07-17 2000-10-10 Janssen Pharmaceutica Nv Péletes que apresentam um núcleo revestido com um antifúngico e um polìmero
ES2157731B1 (es) 1998-07-21 2002-05-01 Liconsa Liberacion Controlada Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion.
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US7863331B2 (en) 1999-07-09 2011-01-04 Ethypharm Pharmaceutical composition containing fenofibrate and method for the preparation thereof
FR2795961B1 (fr) * 1999-07-09 2004-05-28 Ethypharm Lab Prod Ethiques Composition pharmaceutique contenant du fenofibrate micronise, un tensioactif et un derive cellulosique liant et procede de preparation
KR100694667B1 (ko) * 1999-12-08 2007-03-14 동아제약주식회사 생체내이용률 향상과 개인간 및 개인내 흡수 편차를감소시킨 이트라코나졸 함유 항진균성 제제
US6663897B2 (en) * 2001-02-06 2003-12-16 Dsm Ip Assets B.V. Oral itraconazole formulations and methods of making the same
EP1842532A3 (en) * 2001-02-06 2009-04-22 Stiefel Laboratories, Inc. Oral sparingly water-soluble antifungal formulations and methods of making the same
FR2842736B1 (fr) 2002-07-26 2005-07-22 Flamel Tech Sa Formulation pharmaceutique orale sous forme d'une pluralite de microcapsules permettant la liberation prolongee de principe(s) actif(s) peu soluble(s)
ITMI20031096A1 (it) * 2003-05-30 2004-11-30 Eurand Spa Microcapsule per coacervazione contenenti farmaco incorporato nel polimero di rivestimento
DE10355461A1 (de) 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
US20160361322A1 (en) 2015-06-15 2016-12-15 Lipocine Inc. Composition and method for oral delivery of androgen prodrugs
CN105949278B (zh) * 2016-03-30 2019-12-06 南京曼杰生物科技有限公司 一种取代的四氢呋喃水溶性衍生物及其应用
US11559530B2 (en) 2016-11-28 2023-01-24 Lipocine Inc. Oral testosterone undecanoate therapy
AU2019308326B2 (en) 2018-07-20 2025-07-31 Lipocine Inc. Liver disease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5580578A (en) * 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
PH30929A (en) * 1992-09-03 1997-12-23 Janssen Pharmaceutica Nv Beads having a core coated with an antifungal and a polymer.
PL181193B1 (pl) * 1993-12-21 2001-06-29 Schering Corp Nowe pochodne tetrahydrofuranowe o działaniu przeciwgrzybicznym, kompozycja farmaceutyczna do leczenia infekcji grzybiczych oraz sposób wytwarzania tych związków

Also Published As

Publication number Publication date
HUP9903869A2 (hu) 2000-06-28
HUP9903869A3 (en) 2000-07-28
NO986087D0 (no) 1998-12-23
CZ421498A3 (cs) 1999-06-16
IL127780A0 (en) 1999-10-28
JP2000514059A (ja) 2000-10-24
EP0914100A1 (en) 1999-05-12
NO986087L (no) 1999-02-26
AU3387497A (en) 1998-01-21
WO1998000116A1 (en) 1998-01-08
CA2258683C (en) 2007-07-31
KR20000022294A (ko) 2000-04-25
CN1228693A (zh) 1999-09-15
NZ333514A (en) 2000-05-26
TR199802718T2 (xx) 1999-03-22
AU731704B2 (en) 2001-04-05
BR9710069A (pt) 1999-08-10
CA2258683A1 (en) 1998-01-08
SK177598A3 (en) 1999-07-12

Similar Documents

Publication Publication Date Title
PL330864A1 (en) Orally administered composition containing antimycotic compounds of triazole
PL313731A1 (en) Orally administered preparations containing an antimycotic agent
AU4010395A (en) Compositions for increased bioavailability of orally delivered therapeutic agents
GR3035652T3 (en) Topical composition containing an antagonist of substance P
IL116455A0 (en) Imidazole compounds and pharmaceutical compositions containing them
PL339461A1 (en) Orally administered compositions containing levosimendane
HUP0001219A3 (en) Pharmaceutical compositions containing compounds of neurotrophic effect
PL337738A1 (en) Novel substituted compounds of imidazole
IL195339A0 (en) Solid oral dosage forms of valsartan
PL330931A1 (en) Antimycotic agents of improved bioavailability
HUP9802086A3 (en) Pharmaceutical composition for piperidinoalkanol compounds
IL133420A0 (en) Pharmaceutical composition for combination of piperidinoalkanol-decongestant
HUP0104657A3 (en) Imidazole compounds and pharmaceutical compositions containing them
PL324341A1 (en) Pharmaceutic compositions and compounds
ZA9510428B (en) Pharmaceutical orally applicable composition
ZA9510427B (en) Pharmaceutical orally applicable composition
PL315666A1 (en) Heterocyclic compounds of therapeutic properties
IL118425A0 (en) Pharmaceutical composition containing 1H-1,2,4-triazole derivative
IL113248A0 (en) Use of alpha - 1c specific compounds
HUT74746A (en) Pharmaceutical compositions containing p antagonist
AU3481795A (en) Pharmaceutical compositions containing d2o
PL330480A1 (en) Antimycotic composition of enhanced bioavailability
AU1897795A (en) X-ray contrast compositions containing pharmaceutically acceptable clays
GB2315218B (en) Fungicidal composition based on 2 compounds of triazole type
AU4019395A (en) Use of amino-isoxazolidone compounds for improvement of implicit memory